Efficacy of low-dose ibuprofen in acute migraine treatment: Systematic review and meta-analysis

Annals of Pharmacotherapy

Volumn 41, Issue 11, 2007, Pages 1782-1791

  Suthisisang, Chuthamanee ^a   Poolsup, Nalinee ^b   Kittikulsuth, Wararat ^a   Pudchakan, Phutsadee ^a   Wiwatpanich, Pichamon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SILPAKORN UNIVERSITY   (Thailand)

Author keywords

Acute migraine; Ibuprofen

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

CLINICAL TRIAL; DISEASE SEVERITY; DIZZINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; HEADACHE; HUMAN; LOW DRUG DOSE; META ANALYSIS; MIGRAINE; NAUSEA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TABLET; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR HEADACHE; VOMITING; XEROSTOMIA;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; MALE; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 35748953454     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K121     Document Type: Review

References (29)

1. Headache Classification Committee for the International Headache Society. The international classification of headache disorders: second edition. Cephalalgia 2004;24(suppl 1):1-151.
2. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;45(suppl 1):S3-13.
3. Wenzel RG, Sarvis CA, Krause ML. Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy 2003;23:494-505.
4. Landy S. Migraine throughout the life cycle. Treatment through the ages. Neurology 2004;62(suppl 2):S2-8.
5. Krymchantowski AV. Acute treatment of migraine. Breaking the paradigm of monotherapy. BMC Neurol 2004;4:4. DOI 10.1186/1474-2377-4-4
6. Snow V, Weiss K, Wall EM, Mottur-Pilson C; for the American Academy of Family Physicians and the American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002;137:840-9.
7. Silberstein SD. Migraine. Lancet 2004;363:381-91.
8. Tonore TB, King DS, Noble SL. Do over-the-counter medications for migraine hinder physician? Curr Pain Headache Rep 2002;6:162-7.
9. Jenkins DW, Feniuk W, Humphrey PP. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol 2001;134:1296-302.
10. Pearce I, Frank GJ, Pearce JM. Ibuprofen compared with paracetamol in migraine. Practitioner 1983;227:465-7.
11. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989;29:507-9.
12. Kloster R, Nestvold K, Vilming ST, et al. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992;12:169-71.
13. Nebe J, Heier M, Diener HC, et al. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995;15:531-5.
14. Codispoti JR, Prior MJ, Fu M, et al. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial. Headache 2001;41:665-79.
15. Misra UK, Jose M, Kalita J, et al. Rofecoxib versus ibuprofen for acute treatment of migraine: a randomized placebo controlled trial. Postgrad Med J 2004;80:720-3.
16. Diener HC, Bussone G, de Liano H, et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 2004;24:947-54.
17. Saper J, Dahlof C, So Y, et al. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. Headache 2006;46:264-75.
18. Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 2006;46:444-53.
19. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
20. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. London: John Wiley & Sons, Ltd., 2000.
21. Higgin JP, Thompson SG, Deeks JJ, Altaian DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
22. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
23. Hamalainen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997; 48:103-7.
24. Sandrini G, Franchini S, Lanfranchi S, et al. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res 1998;18:145-50.
25. Lewis DW, Kellstein D, Dahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002;42:780-6.
26. Kellstein DE, Lipton RB, Geetha R, et al. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 2000;20:233-43.
27. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20:765-86.
28. Oldman AD, Smith LA, McQuay HJ, Moore A. Pharmacological treatments for acute migraine: quantitative systematic reviews. Pain 2002; 97:247-57.
29. Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW. Symptomatic treatment of migraine in children: a systematic review of medical trials. Pediatrics 2005;116:e295-e302.